Sonnet BioTherapeutics Holdings Inc (SONN)
1.70
-0.11
(-6.10%)
USD |
NASDAQ |
May 10, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
Sonnet BioTherapeutics Holdings Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2020 | 68.36% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
68.36%
Minimum
Mar 2020
68.36%
Maximum
Mar 2020
68.36%
Average
68.36%
Median
Mar 2020
Gross Profit Margin (Quarterly) Benchmarks
ACADIA Pharmaceuticals Inc | 88.85% |
Ainos Inc | -559.7% |
CytomX Therapeutics Inc | -- |
Amylyx Pharmaceuticals Inc | -31.32% |
CERo Therapeutics Holdings Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -951.7% |
Return on Assets | -185.1% |
Return on Invested Capital | -951.5% |
Profit Margin (Quarterly) | -6.27K% |
Operating Margin (Quarterly) | -6.87K% |
Return on Net Operating Assets | -239.8% |